Skip to main content

Advertisement

SpringerLink
Log in

Increased Plasma Levels of Brain Derived Neurotrophic Factor (BDNF) in Patients with Fibromyalgia

  • Original Research
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Brain-derived neurotrophic factor (BDNF) is involved in neuronal survival and synaptic plasticity of the central and peripheral nervous system. BDNF appears to modulate nociceptive sensory inputs and pain hypersensitivity and has been studied in pathological situations, including chronic pain conditions and major depression. Increased serum BDNF levels have been recently reported in fibromyalgia (FM). In the present study, we assessed plasma BDNF levels in patients with FM and controls. Plasma BDNF was measured from 30 female patients with FM and 30 healthy age- and gender-matched volunteers using an enzyme immunoassay. FM patients showed higher levels of BDNF (FM = 167.1 ± 171.2 pg/mL) when compared with the control group (control = 113.8 ± 149.6 pg/mL) (P = 0.049; Mann–Whitney test). Six out of 30 controls presented superior values to the medium (15/15) of the patients with fibromyalgia (129 pg/mL) (P = 0.029, Fisher exact test). There was no correlation between plasma BDNF levels and age, disease duration, pain score, number of pain points and HAM-D score. Our results confirm previous findings of increased plasma BDNF levels in patients with FM, suggesting that BDNF may be involved in the pathophysiology of Fibromyalgia, despite high levels of depression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mease P (2005) Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 75:6–21

    PubMed  Google Scholar 

  2. Gran JT (2003) The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 17:547–561

    Article  PubMed  Google Scholar 

  3. Katz RS, Wolfe F, Michaud K (2006) Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 54:169–176

    Article  PubMed  Google Scholar 

  4. Meeus M, Nijs J (2007) Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol 26:465–473

    Article  PubMed  Google Scholar 

  5. Schwarz MJ, Spath M, Muller-Bardorff H (1999) Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Neurosci Lett 259:196–198

    Article  CAS  PubMed  Google Scholar 

  6. Julien N, Goffaux P, Arsenault P (2005) Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114:295–302

    Article  PubMed  Google Scholar 

  7. Kassam A, Patten SB (2006) Major depression, fibromyalgia and labour force participation: a population-based cross-sectional study. BMC Musculoskelet Disord 7:4

    Google Scholar 

  8. Laske C, Stransky E, Eschweiler GW (2007) Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psychiatr Res 41:600–605

    Article  PubMed  Google Scholar 

  9. Suhr JA (2003) Neuropsychological impairment in fibromyalgia: relation to depression, fatigue, and pain. J Psychosom Res 55:321–329

    Article  PubMed  Google Scholar 

  10. Wu YJ, Kruttgen A, Moller JC, Len G, McAuliffe G, Ma C, Tai JP, Xu F (2004) Nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 are sorted to dense-core vesicles and released via the regulated pathway in primary rat cortical neurons. J Neurosci Res 75:825–834

    Article  CAS  PubMed  Google Scholar 

  11. Malcangio M, Lessmann V (2003) A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors. Trends Pharmacol Sci 24:116–121

    Article  CAS  PubMed  Google Scholar 

  12. Delafoy L, Gelot A, Ardid D (2006) Interactive involvement of brain derived neurotrophic factor, nerve growth factor, and calcitonin gene related peptide in colonic hypersensitivity in the rat. Gut 55:940–945

    Article  CAS  PubMed  Google Scholar 

  13. Groth R, Aanonsen L (2002) Spinal brain-derived neurotrophic factor (BDNF) produces hyperalgesia in normal mice while antisense directed against either BDNF or trkB, prevent inflammation-induced hyperalgesia. Pain 100:171–181

    Article  CAS  PubMed  Google Scholar 

  14. Wu K, Len GW, McAuliffe G (2004) Brain-derived neurotrophic factor acutely enhances tyrosine phosphorylation of the AMPA receptor subunit GluR1 via NMDA receptor-dependent mechanisms. Brain Res Mol Brain Res 130:178–186

    Article  CAS  PubMed  Google Scholar 

  15. Yoshimura R, Mitoma M, Sugita A et al (2007) Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 31:1034–1037

    Article  CAS  PubMed  Google Scholar 

  16. Karege F, Perret G, Bondolfi G (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109:143–148

    Article  CAS  PubMed  Google Scholar 

  17. Aydemir O, Deveci A, Taneli F (2005) The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29:261–265

    Article  CAS  PubMed  Google Scholar 

  18. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54:70–75

    Article  CAS  PubMed  Google Scholar 

  19. Piccinni A, Marazziti D, Catena M et al (2007) Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord 105:279–283

    Article  PubMed  Google Scholar 

  20. Chen B, Dowlatshahi D, MacQueen GM (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50:260–265

    Article  CAS  PubMed  Google Scholar 

  21. Sarchielli P, Mancini ML, Floridi A et al (2007) Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain 8:737–745

    Article  CAS  PubMed  Google Scholar 

  22. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62

    Article  CAS  PubMed  Google Scholar 

  23. Duric V, McCarson KE (2006) Effects of analgesic or antidepressant drugs on pain- or stress-evoked hippocampal and spinal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression in the rat. J Pharmacol Exp Ther 319:1235–1243

    Article  CAS  PubMed  Google Scholar 

  24. Duric V, McCarson KE (2006) Persistent pain produces stress-like alterations in hippocampal neurogenesis and gene expression. J Pain 7:544–555

    Article  PubMed  Google Scholar 

  25. Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539–7547

    CAS  PubMed  Google Scholar 

  26. Lee J, Duan W, Mattson MP (2002) Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 82:1367–1375

    Article  CAS  PubMed  Google Scholar 

  27. Sairanen M, Lucas G, Ernfors P (2005) Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 25:1089–1094

    Article  CAS  PubMed  Google Scholar 

  28. Pezet S, Cunningham J, Patel J (2002) BDNF modulates sensory neuron synaptic activity by a facilitation of GABA transmission in the dorsal horn. Mol Cell Neurosci 21:51–62

    Article  CAS  PubMed  Google Scholar 

  29. Pezet S, Malcangio M, Lever IJ (2002) Noxious stimulation induces Trk receptor and downstream ERK phosphorylation in spinal dorsal horn. Mol Cell Neurosci 21:684–695

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departamento de Ciências Fisiológicas, Faculdade de Biociências, Pontifícia Universidade Católica do Rio Grande do Sul, Av. Ipiranga, 6681 – Pd 12, Porto Alegre, RS, 90619-900, Brazil

    Lisete Haas & Diogo R. Lara

  2. Departamento de Bioquímica, ICBS, UFRGS, Porto Alegre, Brazil

    Luis V. C. Portela & Ana Elisa Böhmer

  3. Universidade Católica de Pelotas, Pelotas, Brazil

    Jean Pierre Oses

Authors
  1. Lisete Haas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luis V. C. Portela
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ana Elisa Böhmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean Pierre Oses
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Diogo R. Lara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Diogo R. Lara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haas, L., Portela, L.V.C., Böhmer, A.E. et al. Increased Plasma Levels of Brain Derived Neurotrophic Factor (BDNF) in Patients with Fibromyalgia. Neurochem Res 35, 830–834 (2010). https://doi.org/10.1007/s11064-010-0129-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-010-0129-z

Keywords

Search

Navigation